Accendra Health Inc (ACH) stock
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)
Close on Nov 13, 2026Market cap $10.00MP/E –Yield –
Accendra Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Accendra Health's operating cash flow for the twelve months ending Sep 30, 2026 was -$25.31M. For fiscal 2025 it was -$101.79M, down 163.0% from the year before. The highest annual figure on record is $740.71M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$101.79M | -163.0% |
| FY2024 | Dec 31, 2024 | $161.50M | -78.2% |
| FY2023 | Dec 31, 2023 | $740.71M | +127.9% |
| FY2022 | Dec 31, 2022 | $325.01M | +161.7% |
| FY2021 | Dec 31, 2021 | $124.18M | -63.4% |
| FY2020 | Dec 31, 2020 | $339.22M | +104.2% |
| FY2019 | Dec 31, 2019 | $166.09M | +43.7% |
| FY2018 | Dec 31, 2018 | $115.59M | +103.6% |
| FY2017 | Dec 31, 2017 | $56.77M | -69.8% |
| FY2016 | Dec 31, 2016 | $187.70M | -30.5% |
| FY2015 | Dec 31, 2015 | $270.24M | – |
| FY2014 | Dec 31, 2014 | -$3.76M | -102.7% |
| FY2013 | Dec 31, 2013 | $140.55M | -35.7% |
| FY2012 | Dec 31, 2012 | $218.51M | +219.4% |
| FY2011 | Dec 31, 2011 | $68.42M | -52.2% |
| FY2010 | Dec 31, 2010 | $143.18M | -34.3% |
| FY2009 | Dec 31, 2009 | $218.04M | +246.8% |
| FY2008 | Dec 31, 2008 | $62.88M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$17.41M | – |
| Q2 FY2026 | Jun 30, 2026 | -$26.01M | -169.1% |
| Q1 FY2026 | Mar 31, 2026 | -$50.08M | – |
| Q4 FY2025 | Dec 31, 2025 | $68.19M | -4.0% |
| Q3 FY2025 | Sep 30, 2025 | -$172.52M | -731.8% |
| Q2 FY2025 | Jun 30, 2025 | $37.61M | -67.6% |
| Q1 FY2025 | Mar 31, 2025 | -$35.07M | – |
| Q4 FY2024 | Dec 31, 2024 | $71.00M | -36.5% |
| Q3 FY2024 | Sep 30, 2024 | $27.31M | -82.7% |
| Q2 FY2024 | Jun 30, 2024 | $116.15M | -62.9% |
| Q1 FY2024 | Mar 31, 2024 | -$52.96M | -133.4% |
| Q4 FY2023 | Dec 31, 2023 | $111.77M | +28.5% |
| Q3 FY2023 | Sep 30, 2023 | $157.44M | +129.8% |
| Q2 FY2023 | Jun 30, 2023 | $313.11M | +248.6% |
| Q1 FY2023 | Mar 31, 2023 | $158.40M | +98.7% |
| Q4 FY2022 | Dec 31, 2022 | $86.96M | +72.7% |
| Q3 FY2022 | Sep 30, 2022 | $68.52M | +11.5% |
| Q2 FY2022 | Jun 30, 2022 | $89.83M | – |
| Q1 FY2022 | Mar 31, 2022 | $79.70M | +213.5% |
| Q4 FY2021 | Dec 31, 2021 | $50.34M | -29.1% |
| Q3 FY2021 | Sep 30, 2021 | $61.43M | -47.8% |
| Q2 FY2021 | Jun 30, 2021 | -$13.02M | -122.8% |
| Q1 FY2021 | Mar 31, 2021 | $25.42M | -72.8% |
| Q4 FY2020 | Dec 31, 2020 | $71.03M | +163.3% |
| Q3 FY2020 | Sep 30, 2020 | $117.74M | +6.9% |
| Q2 FY2020 | Jun 30, 2020 | $57.00M | -36.6% |
| Q1 FY2020 | Mar 31, 2020 | $93.45M | – |
| Q4 FY2019 | Dec 31, 2019 | $26.98M | – |
| Q3 FY2019 | Sep 30, 2019 | $110.09M | +44.4% |
| Q2 FY2019 | Jun 30, 2019 | $89.92M | +221.4% |
| Q1 FY2019 | Mar 31, 2019 | -$60.90M | -433.3% |
| Q4 FY2018 | Dec 31, 2018 | -$6.92M | -113.5% |
| Q3 FY2018 | Sep 30, 2018 | $76.26M | -13.5% |
| Q2 FY2018 | Jun 30, 2018 | $27.98M | – |
| Q1 FY2018 | Mar 31, 2018 | $18.27M | – |
| Q4 FY2017 | Dec 31, 2017 | $51.13M | +18.4% |
| Q3 FY2017 | Sep 30, 2017 | $88.14M | – |
| Q2 FY2017 | Jun 30, 2017 | -$56.14M | – |
| Q1 FY2017 | Mar 31, 2017 | -$26.36M | – |
| Q4 FY2016 | Dec 31, 2016 | $43.18M | – |
See a number that looks wrong?